Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
Carcinoma, Neuroendocrine
×
Bevacizumab
×
NET
×
Clear all
Filters
3
NCT01203306
2010-09-16
XELBEVOCT
University of Turin, Italy
Phase 2
Unknown
42 enrolled